Starling Oncology Institute share price logo

Starling Oncology Institute

NASDAQ: STLN

Small Cap

$6.96

+0.33

(+4.98%)

as on

Starling Oncology Institute Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.67
    $7.13
    downward going graph

    4.17%

    Downside

    2.44%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Starling Oncology Institute share price movements today

Previous Close
$6.63
Open
$6.80
Volume
1.7M
Market Cap
$665.5M
Day's Low - High
$6.67 - $7.13

Starling Oncology Institute Historical Returns

1 Month Return
-0.45 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Starling Oncology Institute Stock Fundamentals & Key Indicators

Check Starling Oncology Institute market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$665.5M

EPS (TTM)

-0.3

Dividend Yield

0.00%

PE Ratio (TTM)

-22.1

Industry PE ratio

0.00

PEG Ratio

0.3285135135135135

Return On Equity TTM

209.81%

Starling Oncology Institute Stock Valuation

Track how Starling Oncology Institute P/E has moved over time to understand its valuation trends.

Starling Oncology Institute in the last 5 years

  • Overview

  • Trends

Lowest (-59.10x)

December 31, 2021

Industry (0.00x)

December 31, 2025

Today (-10.74x)

December 31, 2025

Highest (790.19x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -10.74x

Starling Oncology Institute vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Starling Oncology Institute with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$665.5MNA-22.115.69%0.00%
BUY$21.1B259.26%10.1310.27%0.00%
HOLD$12.4B50.63%15.7431.02%0.00%
BUY$12.0B62.2%19.6173.13%0.61%
BUY$91.8B65.82%14.1528.36%0.71%

Analyst Recommendation on Starling Oncology Institute Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Starling Oncology Institute. Average target price of $9.25

Indian Investors' Interest in Starling Oncology Institute Stock

Search interest for Starling Oncology Institute Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Starling Oncology Institute Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
94
98
99
100
104
119
136
141
147
161
Gross Profit
11
13
14
14
17
17
18
22
23
27
Operating Income
-17
-16
-13
-11
-9
-11
-8
-6
-6
-4
EBITDA
-16
-11
-12
-10
-12
-13
-12
-3
1
-6
Interest Expense
1
2
2
1
5
1
1
1
1
1
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-19
-15
-16
-13
-19
-17
-16
-7
-2
-9
Income Tax Expense
-
-
-
-
-
0
-
-
-
-
Net Income
-19
-15
-16
-13
-19
-17
-16
-7
-2
-9
Net Profit Margin
12.64%
13.21%
14.38%
14.60%
16.52%
14.61%
13.85%
16.04%
15.81%
16.84%

Starling Oncology Institute Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
155
187
203
252
324
393
502
Gross Profit
29
36
40
52
59
53
76
Operating Income
-2
-8
-45
-81
-77
-60
-36
EBITDA
0
-11
-42
-67
-54
-50
-42
Interest Expense
0
0
0
4
6
7
11
Depreciation
2
3
3
4
5
6
6
Income Before Tax
-2
-14
-11
0
-83
-64
-60
Income Tax Expense
1
0
0
0
0
-
0
Net Income
-4
-14
-10
0
-83
-64
-60
Net Profit Margin
19.27%
19.67%
20.12%
20.63%
18.37%
13.73%
15.20%

Starling Oncology Institute Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-12
-16
-13
-19
-17
-16
-7
-2
-9
Operating Cash Flow
-15
-15
0
4
-4
-10
-12
3
-2
11
Investing Cash Flow
19
18
10
-1
0
-1
0
-1
-1
0
Financing Cash Flow
0
-2
0
0
-4
1
10
3
0
0
Change in Cash
2
0
10
2
-9
-9
-2
5
-3
10

Starling Oncology Institute Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-14
-10
0
-83
-53
-60
Operating Cash Flow
3
0
-32
-61
-36
-26
-24
Investing Cash Flow
-1
-8
-12
-131
62
46
-3
Financing Cash Flow
0
11
154
92
-6
-3
11
Change in Cash
2
3
109
-101
19
16
-16

Mutual Funds that own Starling Oncology Institute Stock

Check out the Mutual Funds with significant holdings in Starling Oncology Institute.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.385264%
3384687
World Funds Trust
0.87838%
878231
Fidelity Salem Street Trust
0.859955%
859809
Fidelity Concord Street Trust
0.695313%
695195
VANGUARD SCOTTSDALE FUNDS
0.406163%
406094

Global Institutional Holdings in Starling Oncology Institute

Funds
Holdings
Vanguard
4.25%
James E. Flynn
3.36%
iShares
2.99%
Charles Davidson
1.71%
Fidelity
0.48%

Insights on Starling Oncology Institute

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, STLN stock has moved up by 12.8%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, STLN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, STLN has outperformed top 5 stocks with highest market-cap in its industry

About Starling Oncology Institute

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
OrganisationStarling Oncology Institute
Headquarters18000 Studebaker Road, Suite 800, Cerritos, CA, 90703, US
IndustryMedical - Care Facilities
CEODaniel Virnich
E-voting on sharesClick here to vote

Key Management of Starling Oncology Institute

Name

Title

Dr. Daniel Virnich FACHE, M.B.A., M.D.

CEO & Executive Director

Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.

Chief Medical Officer

Mr. Rakesh Panda

Chief Information Officer

Mr. Nolan Mariano

Chief People Officer

Mr. Mark Hueppelsheuser Esq.

General Counsel

Mr. Jordan McInerney

Chief Development Officer

Mr. Robert Carter

Chief Financial Officer

Mr. Austin Lee

VP of Accounting & Controller

Ms. Minh Merchant

Chief Legal Officer

Mr. Stephen Cella

Senior Vice President of Finance

FAQs

What is Starling Oncology Institute share price today?

Starling Oncology Institute share price today is $6.96 as on at the close of the market. Starling Oncology Institute share today touched a day high of $7.13 and a low of $6.67.

What is the 52 week high and 52 week low for Starling Oncology Institute share?

Starling Oncology Institute share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Starling Oncology Institute stock price today i.e. is closed at $6.96,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Starling Oncology Institute's market capitalisation today?

Starling Oncology Institute market capitalisation is $0.00T as on .

How to invest in Starling Oncology Institute Stock (STLN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Starling Oncology Institute on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Starling Oncology Institute Shares that will get you 0.2155 shares as per Starling Oncology Institute share price of $6.96 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Starling Oncology Institute Stock (STLN) from India?

Indian investors can start investing in Starling Oncology Institute (STLN) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Starling Oncology Institute stock (as per the Rupee-Dollar exchange rate as on ). Based on Starling Oncology Institute share’s latest price of $6.96 as on September 19, 2026 at 8:46 am IST, you will get 1.4368 shares of Starling Oncology Institute. Learn more about fractional shares .